DANELLE RODRIGUEZ: Open Payments
NPI 1093192502 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 69 payments from 14 companies in 2025. Trend: 2023 $1,732 · 2024 $1,767 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $302 |
| GENZYME CORPORATION | 16 | $292 |
| GlaxoSmithKline, LLC. | 18 | $268 |
| Grifols USA, LLC | 6 | $127 |
| Electromed, Inc. | 8 | $88 |
| Amgen Inc. | 4 | $84 |
| Viatris Specialty LLC | 3 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Verona Pharma, Inc. | 2 | $65 |
| Insmed, Inc. | 2 | $45 |
Products named: AIRSUPRA, DUPIXENT, NUCALA, Prolastin-C Liquid, SMARTVEST, YUPELRI, TEZSPIRE, Ohtuvayre.
Industry payments across AZ — which companies pay providers there.
